Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study.

Autor: de la Court JR; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl., Woudt SHS; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Schoffelen AF; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Heijmans J; Department of Haematology, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Jonge NA; Department of Haematology, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van der Bruggen T; Department of Medical Microbiology, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands., Bomers MK; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Lambregts MMC; Department of Infectious Diseases, Leiden University Medical Centre, Leiden University, Leiden, The Netherlands., Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Sigaloff KCE; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2022 Nov 28; Vol. 21 (1), pp. 54. Date of Electronic Publication: 2022 Nov 28.

Empirische antibiotische therapie voor koorts bij neutropenie in Nederland

Autor: de la Court, J, Janssen, J, de Jonge, N, Bomers, M, Lambregts, M, Woudt, S, Kuijvenhoven, M, van der Bruggen, T, Schade, R, Sigaloff, K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::172c953918a92ee301db839ad909594e
http://hdl.handle.net/10029/622976

Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient.

Autor: Besteman SB; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands., Phung E; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Raeven HHM; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Amatngalim GD; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rumpret M; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Crabtree J; Department of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Schepp RM; National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Rodenburg LW; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Siemonsma SG; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands., Verleur N; Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands., van Slooten R; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands., Duran K; Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., van Haaften GW; Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Beekman JM; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Chang LA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Meyaard L; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van der Bruggen T; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands., Berbers GAM; National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Derksen N; RSV Patient Network, ReSVinet, Zeist, the Netherlands., Nierkens S; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands., Morabito KM; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ruckwardt TJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kurt-Jones EA; Department of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Golenbock D; Department of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Bont LJ; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2022 Aug 24; Vol. 226 (2), pp. 258-269.

Anti-HIV effect of iron chelators: different mechanisms involved

Autor: van Asbeck, B.S. ^*, Georgiou, N.A., van der Bruggen, T., Oudshoorn, M., Nottet, H.S.L.M., Marx, J.J.M.

Publikováno v: In Journal of Clinical Virology 2001 20(3):141-147